Commercial Information Circulars
24-hour hotline : 23 922 922
e-mail address : enquiry@tid.gov.hk
Ref. : EIC 631/2/5/1
2 April 2020
Dear Sirs,
Commercial Information Circular No. 279/2020
The Mainland of China : Notice Concerning Certain Implementation Issues Related to the Amended "Measures on Supervision and Administration of Drug Production"
The National Medical Products Administration issued on 30 March 2020 the "Notice Concerning Certain Implementation Issues Related to the Amended 'Measures on Supervision and Administration of Drug Production'". Please refer to the Appendix (pdf format) for the notice (available in Chinese only).
ENQUIRIES
2.If you have any questions on the content of the document mentioned in this circular, please contact the issuing authority of the Mainland of China direct. For other questions on this circular, please contact Mainland Branch (I) (tel: 2398 5444) of the Department.
Yours faithfully,
(Calvin CHOY)
for Director-General of Trade and Industry
Note: While every effort is made to ensure the accuracy of the above information, the Department cannot guarantee this to be so and will not be held liable for any reliance placed on the same.